| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHDERM.1979.04010120007006 |
| P2093 | author name string | Richard D. Sontheimer | |
| P433 | issue | 12 | |
| P921 | main subject | subacute cutaneous lupus erythematosus | Q7630706 |
| P304 | page(s) | 1409 | |
| P577 | publication date | 1979-12-01 | |
| P1433 | published in | Archives of Dermatology | Q15749524 |
| P1476 | title | Subacute Cutaneous Lupus Erythematosus | |
| P478 | volume | 115 |
| Q70332838 | A case of subacute cutaneous lupus erythematosus with a high titer of RNP antibody |
| Q72404203 | Acral subacute cutaneous lupus erythematosus: an unusual variant |
| Q44198919 | Annular erythema associated with lupus erythematosus/Sjögren's syndrome |
| Q69600584 | Annular erythema: a possible association with primary Sjögren's syndrome |
| Q70621675 | Annular subacute cutaneous lupus erythematosus responsive to dapsone |
| Q39823082 | Antinuclear antibodies in autoimmune disease. Significance and pathogenicity. |
| Q44545529 | Antinuclear antibody determinations in Ro(SSA)-positive, antinuclear antibody--negative lupus and Sjögren's syndrome patients |
| Q72086058 | Antinuclear antibody-negative systemic lupus erythematosus. I. Anti-Ro(SSA) and anti-La(SSB) antibodies |
| Q70340830 | Clearing of subacute cutaneous lupus erythematosus around molluscum contagiosum lesions |
| Q36736069 | Collagen vascular disease. |
| Q70264075 | Complement-Activating Immune Deposits in Systemic Lupus Erythematosus Skin |
| Q69531792 | Cutaneous immunofluorescence |
| Q38682555 | Cutaneous lesions in systemic lupus erythematosus. |
| Q70765321 | Distinctive cutaneous subsets in the spectrum of lupus erythematosus |
| Q77747370 | Distinguishing subacute cutaneous from other types of lupus erythematosus |
| Q37778650 | Drug-induced subacute cutaneous lupus erythematosus |
| Q40079107 | Eczematous and immunologic diseases |
| Q22299248 | Epidemiology and socioeconomic impact of skin disease in lupus erythematosus |
| Q42483873 | Expression of intercellular adhesion molecule-1 (ICAM-1) and OKM5 in UVA- and UVB-induced lesions in patients with lupus erythematosus and polymorphous light eruption |
| Q41249229 | Immunofluorescence microscopy of healthy skin from patients with systemic lupus erythematosus: more than just the lupus band |
| Q68189330 | Large speckle-like thready and thready antinuclear antibody patterns as markers for different clinical presentations in lupus erythematosus |
| Q72621027 | Lupus Erythematosus: Laboratory Testing and Clinical Subsets in the Evaluation of Patients |
| Q67290871 | Lupus erythematosus |
| Q70027902 | Lupus erythematosus |
| Q69061961 | Lupus erythematosus and toxic epidermal necrolysis |
| Q70877444 | Neonatal Lupus Erythematosus: New Serologic Findings |
| Q71071712 | Neonatal lupus syndrome in successive pregnancies |
| Q40212922 | Oral manifestations of lupus erythematosus |
| Q37778645 | Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates |
| Q38001712 | Pathogenesis of anti-Ro/SS-A autoantibody-associated cutaneous lupus erythematosus. |
| Q37778644 | Photosensitivity, phototesting, and photoprotection in cutaneous lupus erythematosus |
| Q70027896 | Polymorphous light eruption |
| Q68812610 | Questions pertaining to the true frequencies with which anti-Ro/SS-A autoantibody and the HLA-DR3 phenotype occur in subacute cutaneous lupus erythematosus patients |
| Q70382442 | Relationships between antinuclear and anti-Ro/SS-A antibodies in subacute cutaneous lupus erythematosus |
| Q77227065 | Relevance of complement fixing antinuclear antibodies |
| Q40733320 | Serologic tests for connective tissue diseases and the primary vasculitides. |
| Q41033561 | Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease |
| Q39701519 | Skin and nail changes in the arthritic foot |
| Q70325341 | Skin lesions associated with Sjögren's syndrome and anticytoplasmic antibodies in SLE patients |
| Q70876328 | Subacute cutaneous lupus erythematosus and porphyria cutanea tarda |
| Q68488736 | Subacute cutaneous lupus erythematosus associated with breast carcinoma |
| Q69087910 | Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin |
| Q70059962 | Subacute cutaneous lupus erythematosus presenting as erythroderma |
| Q73372423 | Subacute cutaneous lupus erythematosus presenting with generalized poikiloderma |
| Q74371917 | Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications |
| Q68275829 | Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene |
| Q68929209 | Subacute cutaneous lupus erythematosus. Clinical, serologic, and immunogenetic studies of forty-nine patients seen in a nonreferral setting |
| Q38682548 | Subacute cutaneous lupus erythematosus: a decade's perspective. |
| Q71867653 | Systemic lupus erythematosus in patients diagnosed with treatment-resistant acne |
| Q69865356 | Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients |
| Q41932262 | Systemic lupus erythematosus: Nephritis, dilated cardiomyopathy, and extensive cutaneous depigmentation responsive to hydroxychloroquine |
| Q34135760 | The cutaneous pathology of lupus erythematosus: a review |
| Q73954733 | The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus |
| Q37778654 | The impact of the EUSCLE core set questionnaire for the assessment of cutaneous lupus erythematosus |
| Q70409076 | Therapy of cutaneous lupus erythematosus |
| Q41930396 | Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy |
| Q93561526 | [C2 deficiency and diseases. Apropos of a case of discoid lupus] |
Search more.